PRO-DEX INC (PDEX) Stock Fundamental Analysis
NASDAQ:PDEX - Nasdaq - US74265M2052 - Common Stock - Currency: USD
We assign a fundamental rating of 6 out of 10 to PDEX. PDEX was compared to 189 industry peers in the Health Care Equipment & Supplies industry. While PDEX belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. PDEX has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination! These ratings would make PDEX suitable for value and growth investing!
1. Profitability
1.1 Basic Checks
PDEX had positive earnings in the past year.
PDEX had a positive operating cash flow in the past year.
In the past 5 years PDEX has always been profitable.
In multiple years PDEX reported negative operating cash flow during the last 5 years.
1.2 Ratios
With an excellent Return On Assets value of 11.18%, PDEX belongs to the best of the industry, outperforming 92.51% of the companies in the same industry.
Looking at the Return On Equity, with a value of 21.21%, PDEX belongs to the top of the industry, outperforming 94.12% of the companies in the same industry.
With an excellent Return On Invested Capital value of 18.51%, PDEX belongs to the best of the industry, outperforming 97.86% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for PDEX is above the industry average of 8.00%.
The last Return On Invested Capital (18.51%) for PDEX is above the 3 year average (11.81%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.18% | ||
| ROE | 21.21% | ||
| ROIC | 18.51% |
ROA(3y)9%
ROA(5y)12.39%
ROE(3y)15.75%
ROE(5y)22.01%
ROIC(3y)11.81%
ROIC(5y)13.41%
1.3 Margins
Looking at the Profit Margin, with a value of 11.06%, PDEX belongs to the top of the industry, outperforming 85.56% of the companies in the same industry.
In the last couple of years the Profit Margin of PDEX has declined.
Looking at the Operating Margin, with a value of 16.83%, PDEX belongs to the top of the industry, outperforming 88.24% of the companies in the same industry.
In the last couple of years the Operating Margin of PDEX has declined.
PDEX has a Gross Margin of 30.02%. This is in the lower half of the industry: PDEX underperforms 76.47% of its industry peers.
PDEX's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.83% | ||
| PM (TTM) | 11.06% | ||
| GM | 30.02% |
OM growth 3Y3.8%
OM growth 5Y-6.22%
PM growth 3Y-37.56%
PM growth 5Y-23.7%
GM growth 3Y-8.87%
GM growth 5Y-5.57%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), PDEX is creating value.
The number of shares outstanding for PDEX has been reduced compared to 1 year ago.
PDEX has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, PDEX has an improved debt to assets ratio.
2.2 Solvency
PDEX has an Altman-Z score of 5.15. This indicates that PDEX is financially healthy and has little risk of bankruptcy at the moment.
PDEX has a Altman-Z score of 5.15. This is in the better half of the industry: PDEX outperforms 79.14% of its industry peers.
PDEX has a debt to FCF ratio of 10.01. This is a negative value and a sign of low solvency as PDEX would need 10.01 years to pay back of all of its debts.
The Debt to FCF ratio of PDEX (10.01) is better than 72.73% of its industry peers.
A Debt/Equity ratio of 0.33 indicates that PDEX is not too dependend on debt financing.
PDEX has a Debt to Equity ratio (0.33) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.33 | ||
| Debt/FCF | 10.01 | ||
| Altman-Z | 5.15 |
ROIC/WACC2.15
WACC8.6%
2.3 Liquidity
PDEX has a Current Ratio of 2.58. This indicates that PDEX is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of PDEX (2.58) is comparable to the rest of the industry.
A Quick Ratio of 1.44 indicates that PDEX should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.44, PDEX is not doing good in the industry: 61.50% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.58 | ||
| Quick Ratio | 1.44 |
3. Growth
3.1 Past
PDEX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 168.00%, which is quite impressive.
Measured over the past years, PDEX shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.76% on average per year.
PDEX shows a strong growth in Revenue. In the last year, the Revenue has grown by 26.44%.
Measured over the past years, PDEX shows a quite strong growth in Revenue. The Revenue has been growing by 14.66% on average per year.
EPS 1Y (TTM)168%
EPS 3Y-17.89%
EPS 5Y-6.76%
EPS Q2Q%335.71%
Revenue 1Y (TTM)26.44%
Revenue growth 3Y12.29%
Revenue growth 5Y14.66%
Sales Q2Q%33.4%
3.2 Future
The Earnings Per Share is expected to grow by 84.09% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 12.93% on average over the next years. This is quite good.
EPS Next Y229.03%
EPS Next 2Y84.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year23.48%
Revenue Next 2Y12.93%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 17.27, the valuation of PDEX can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of PDEX indicates a rather cheap valuation: PDEX is cheaper than 87.70% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.43, PDEX is valued a bit cheaper.
PDEX is valuated correctly with a Price/Forward Earnings ratio of 16.52.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PDEX indicates a rather cheap valuation: PDEX is cheaper than 86.63% of the companies listed in the same industry.
PDEX's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.67.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.27 | ||
| Fwd PE | 16.52 |
4.2 Price Multiples
91.44% of the companies in the same industry are more expensive than PDEX, based on the Enterprise Value to EBITDA ratio.
70.05% of the companies in the same industry are more expensive than PDEX, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 69.14 | ||
| EV/EBITDA | 10.19 |
4.3 Compensation for Growth
PDEX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of PDEX may justify a higher PE ratio.
A more expensive valuation may be justified as PDEX's earnings are expected to grow with 84.09% in the coming years.
PEG (NY)0.08
PEG (5Y)N/A
EPS Next 2Y84.09%
EPS Next 3YN/A
5. Dividend
5.1 Amount
PDEX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:PDEX (2/28/2025, 8:07:35 PM)
34.72
+0.99 (+2.94%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners31.57%
Inst Owner Change27.14%
Ins Owners36.12%
Ins Owner Change2.38%
Market Cap113.19M
Analysts82.86
Price Target53.04 (52.76%)
Short Float %0.86%
Short Ratio0.6
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)105.46%
Min EPS beat(2)57.38%
Max EPS beat(2)153.55%
EPS beat(4)3
Avg EPS beat(4)48.25%
Min EPS beat(4)-46.78%
Max EPS beat(4)153.55%
EPS beat(8)5
Avg EPS beat(8)5.08%
EPS beat(12)6
Avg EPS beat(12)4.21%
EPS beat(16)7
Avg EPS beat(16)8.33%
Revenue beat(2)2
Avg Revenue beat(2)19.98%
Min Revenue beat(2)19.3%
Max Revenue beat(2)20.66%
Revenue beat(4)4
Avg Revenue beat(4)21.27%
Min Revenue beat(4)6.16%
Max Revenue beat(4)38.97%
Revenue beat(8)7
Avg Revenue beat(8)14.81%
Revenue beat(12)10
Avg Revenue beat(12)12.67%
Revenue beat(16)13
Avg Revenue beat(16)13.18%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.5%
EPS NY rev (1m)0%
EPS NY rev (3m)40.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)7.53%
Revenue NY rev (1m)0%
Revenue NY rev (3m)12.13%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.27 | ||
| Fwd PE | 16.52 | ||
| P/S | 1.86 | ||
| P/FCF | 69.14 | ||
| P/OCF | 39.94 | ||
| P/B | 3.56 | ||
| P/tB | 3.56 | ||
| EV/EBITDA | 10.19 |
EPS(TTM)2.01
EY5.79%
EPS(NY)2.1
Fwd EY6.05%
FCF(TTM)0.5
FCFY1.45%
OCF(TTM)0.87
OCFY2.5%
SpS18.71
BVpS9.76
TBVpS9.75
PEG (NY)0.08
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.18% | ||
| ROE | 21.21% | ||
| ROCE | 23.75% | ||
| ROIC | 18.51% | ||
| ROICexc | 20.78% | ||
| ROICexgc | 20.8% | ||
| OM | 16.83% | ||
| PM (TTM) | 11.06% | ||
| GM | 30.02% | ||
| FCFM | 2.68% |
ROA(3y)9%
ROA(5y)12.39%
ROE(3y)15.75%
ROE(5y)22.01%
ROIC(3y)11.81%
ROIC(5y)13.41%
ROICexc(3y)13.33%
ROICexc(5y)16.93%
ROICexgc(3y)13.36%
ROICexgc(5y)17.03%
ROCE(3y)15.15%
ROCE(5y)17.2%
ROICexcg growth 3Y11.8%
ROICexcg growth 5Y-12.49%
ROICexc growth 3Y11.98%
ROICexc growth 5Y-12.32%
OM growth 3Y3.8%
OM growth 5Y-6.22%
PM growth 3Y-37.56%
PM growth 5Y-23.7%
GM growth 3Y-8.87%
GM growth 5Y-5.57%
F-Score6
Asset Turnover1.01
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.33 | ||
| Debt/FCF | 10.01 | ||
| Debt/EBITDA | 0.91 | ||
| Cap/Depr | 99.17% | ||
| Cap/Sales | 1.96% | ||
| Interest Coverage | 16.54 | ||
| Cash Conversion | 24.7% | ||
| Profit Quality | 24.26% | ||
| Current Ratio | 2.58 | ||
| Quick Ratio | 1.44 | ||
| Altman-Z | 5.15 |
F-Score6
WACC8.6%
ROIC/WACC2.15
Cap/Depr(3y)140.73%
Cap/Depr(5y)342.39%
Cap/Sales(3y)2.61%
Cap/Sales(5y)6.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)168%
EPS 3Y-17.89%
EPS 5Y-6.76%
EPS Q2Q%335.71%
EPS Next Y229.03%
EPS Next 2Y84.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)26.44%
Revenue growth 3Y12.29%
Revenue growth 5Y14.66%
Sales Q2Q%33.4%
Revenue Next Year23.48%
Revenue Next 2Y12.93%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y63.34%
EBIT growth 3Y16.56%
EBIT growth 5Y7.53%
EBIT Next Year56.92%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y142.74%
FCF growth 3YN/A
FCF growth 5Y22%
OCF growth 1Y210.27%
OCF growth 3YN/A
OCF growth 5Y13.23%